Regulating the immunity (Immunomodulatory) in children with wheeze by using homeopathic drug arsenicum album
Phase 4
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2022/03/041250
- Lead Sponsor
- DrSanthosh Kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children between the age of 2 to 5 years suffering from repeated attacks of cold and cough with wheeze of unspecified ethology for more than 3 times in a year with the gap of less than 2 months will be selected for the study.
Exclusion Criteria
1.Children should not be under Homoeopathic treatment for the given condition for at least three months. (wash out period)
2.Presence of obstructive lung disease
3.Other Cardiovascular disease
4.Known chronic infections
5.Congenital disorders
6.Known malignancy
7.Inflammatory connective tissue
8.Should not have received steroid for any clinical conditions for the last three months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in terms of reduction in the frequency , duration and severity of each episode in the intervention arm compared to the placebo arm. <br/ ><br>Timepoint: baseline - Improvement in terms of reduction in the frequency , duration and severity of each episode in the intervention arm compared to the placebo arm assessment repeated at the 3rd and 6th month <br/ ><br>
- Secondary Outcome Measures
Name Time Method Improvement in the Quality-of-Life Score in the intervention arm and placebo arm compared to the base line. <br/ ><br>â?¢Reduction in the investigational parameters in the intervention arm compared to the placebo arm both at baseline and end of the study. <br/ ><br>Timepoint: end of 3rd month, 6th month, 9th month <br/ ><br>